News | December 13, 2021
ICMR Dibrugarh designs kit to detect Omicron variant in two hours
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
It is a novel oral NLRP3 inflammasome inhibitor
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The platform’s technology works as a compression algorithm for molecular testing
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Subscribe To Our Newsletter & Stay Updated
